Sunday
4:00 pm - 8:00 pm
Arrival and Check-in
6:00 pm - 7:00 pm
Dinner
7:30 pm - 7:40 pm
Introductory Comments by GRC Site Staff / Welcome from the GRC Chair
7:40 pm - 9:30 pm
Keynote Session: Towards Understanding and Modulating Transglutaminases in Human Diseases
7:40 pm - 7:50 pm
Opening Remarks
7:50 pm - 8:30 pm
"Evolution and Genomics of Transglutaminases"
8:30 pm - 8:40 pm
Discussion
8:40 pm - 9:20 pm
"Towards Understanding and Modulating Transglutaminases in Human Diseases"
9:20 pm - 9:30 pm
Discussion
Monday
7:30 am - 8:30 am
Breakfast
9:00 am - 12:30 pm
Modulators and Medicinal Chemistry of Transglutaminases
9:00 am - 9:20 am
Introduction by Discussion Leader
9:20 am - 9:45 am
"Discovery of ZED1227: A Direct Inhibitor of TG2"
9:45 am - 9:55 am
Discussion
9:55 am - 10:20 am
"Activity-Based Probes for Tumour-Associated Transglutaminase 2: From Potent and Selective Inhibitors to Radiotracers"
10:20 am - 10:30 am
Discussion
10:30 am - 11:00 am
Coffee Break
11:00 am - 11:25 am
"Inhibition and Conformational Modulation of TG2"
11:25 am - 11:35 am
Discussion
11:35 am - 12:00 pm
"TG2 Inhibition with GK921 Reverses Mesenchymal Transdifferentiation and Radio-Resistance of Glioma Stem Cells"
12:00 pm - 12:10 pm
Discussion
12:10 pm - 12:25 pm
"Allosteric Inhibition Site of Transglutaminase 2 Is Unveiled"
12:25 pm - 12:30 pm
Discussion
12:30 pm - 1:30 pm
Group Photo / Lunch
1:30 pm - 4:30 pm
Free Time
3:00 pm - 4:00 pm
Power Hour
The GRC Power Hour is an optional informal gathering open to all meeting participants. It is designed to help address the challenges women face in science and support the professional growth of women in our communities by providing an open forum for discussion and mentoring.
4:30 pm - 6:00 pm
Poster Session
6:00 pm - 8:00 pm
Transglutaminases in Neurological Diseases
6:00 pm - 6:15 pm
Introduction by Discussion Leader
6:15 pm - 6:35 pm
"Deletion of TG2 from Astrocytes Improves Outcomes After Central Nervous System Injury"
6:35 pm - 6:45 pm
Discussion
6:45 pm - 7:05 pm
"Changes in Glial Cell Functions by TGs in Neurological Diseases"
7:05 pm - 7:15 pm
Discussion
7:15 pm - 7:35 pm
"Beyond TG2 in Neurodegeneration - TG6 Loss and Gain of Function in Spinocerebellar Ataxia 35"
7:35 pm - 7:45 pm
Discussion
7:45 pm - 7:55 pm
"Absence of TG2 Delays Amyloid-Beta Deposition in Alzheimer's Disease"
7:55 pm - 8:00 pm
Discussion
8:00 pm - 9:00 pm
Dinner
Tuesday
7:30 am - 8:30 am
Breakfast
9:00 am - 12:30 pm
Activation and Substrates of Transglutaminases
9:00 am - 9:20 am
Introduction by Discussion Leader
9:20 am - 9:45 am
"ADAM17 as a Promoter of Transglutaminase Activity During Skin Barrier Formation"
9:45 am - 9:55 am
Discussion
9:55 am - 10:20 am
"Mutations in PADI3, TG3 and Its Substrate Trichohyalin Cause Uncombable Hair Syndrome"
10:20 am - 10:30 am
Discussion
10:30 am - 11:00 am
Coffee Break
11:00 am - 11:25 am
"Isozyme-Specific Global Identification and Analysis of Transglutaminase Substrates in Fibrotic Diseases"
11:25 am - 11:35 am
Discussion
11:35 am - 12:00 pm
"TG Regulates Transcriptional Activity by Incorporating Polyamines into the NF-κB-Like Transcription Factor Relish in Drosophila "
12:00 pm - 12:10 pm
Discussion
12:10 pm - 12:25 pm
"A Novel Fluorescence Anisotropy-Based Assay to Investigate the GTP-Binding Site of Human TG2"
12:25 pm - 12:30 pm
Discussion
12:30 pm - 1:30 pm
Lunch
1:30 pm - 4:30 pm
Free Time
4:30 pm - 6:00 pm
Poster Session
6:00 pm - 8:00 pm
Transglutaminases in Inflammatory Diseases and Cellular Stress
6:00 pm - 6:15 pm
Introduction by Discussion Leader
6:15 pm - 6:35 pm
"Inflammation, TG2 and Hypertensive Disorders"
6:35 pm - 6:45 pm
Discussion
6:45 pm - 7:05 pm
"Monocyte- and Macrophage-Derived TG2: A Beneficial or Detrimental Role in Multiple Sclerosis?"
7:05 pm - 7:15 pm
Discussion
7:15 pm - 7:35 pm
"TG2 Regulates NFκB-Pathway and Subsequent Cytokine Storm in Acute Promyelocytic Leukemia"
7:35 pm - 7:45 pm
Discussion
7:45 pm - 7:55 pm
"TG2 Controls Mutated CFTR Trafficking by Modulating HSP70 Expression Through Post-Translational Modification of HSF1"
7:55 pm - 8:00 pm
Discussion
8:00 pm - 9:00 pm
Dinner
Wednesday
7:30 am - 8:30 am
Breakfast
9:00 am - 12:30 pm
Transglutaminases in Hemostasis and Cardiovascular Diseases
9:00 am - 9:20 am
Introduction by Discussion Leader
9:20 am - 9:45 am
"Fibrin(ogen), Factor XIII-A, and Red Blood Cells in Venous Thrombosis"
9:45 am - 9:55 am
Discussion
9:55 am - 10:20 am
"Search for Cellular Source of Circulating FXIII-A Using Conditional Knockout Mice"
10:20 am - 10:30 am
Discussion
10:30 am - 11:00 am
Coffee Break
11:00 am - 11:25 am
"Factor XIII-A, Fibrin Clot Architecture and Tissue Repair in the Cardiovascular System"
11:25 am - 11:35 am
Discussion
11:35 am - 12:00 pm
"The Role of TG2 in the Infarcted and Failing Heart"
12:00 pm - 12:10 pm
Discussion
12:10 pm - 12:25 pm
" Effect of Transglutaminase Conformational Modulation on Vascular Tone "
12:25 pm - 12:30 pm
Discussion
12:30 pm - 1:30 pm
Lunch
1:30 pm - 4:30 pm
Free Time
4:30 pm - 6:00 pm
Poster Session
6:00 pm - 8:00 pm
Transglutaminases in Tissue Remodeling, Fibrosis and Scarring
6:00 pm - 6:15 pm
Introduction by Discussion Leader
6:15 pm - 6:35 pm
"TG2 in Lung Fibrosis: Targeting and Twisting!"
6:35 pm - 6:45 pm
Discussion
6:45 pm - 7:05 pm
"Proteomic Profiling Reveals the TG2 Externalization Pathway in Experimental Model of Kidney Fibrosis"
7:05 pm - 7:15 pm
Discussion
7:15 pm - 7:35 pm
"Factor XIII-A in Corneal Keratocytes and Its Possible Role in Corneal Matrix Stabilization and Wound Healing"
7:35 pm - 7:45 pm
Discussion
7:45 pm - 7:55 pm
"Identification of Transglutaminase Cross-Linking Sites in Collagen"
7:55 pm - 8:00 pm
Discussion
8:00 pm - 9:00 pm
Dinner
Thursday
7:30 am - 8:30 am
Breakfast
8:30 am - 9:00 am
Business Meeting
Nominations for the Next Vice Chair; Fill in Conference Evaluation Forms; Discuss Future Site and Scheduling Preferences; Election of the Next Vice Chair
9:00 am - 12:30 pm
Transglutaminases in Cancer and Energy Metabolism
9:00 am - 9:20 am
Introduction by Discussion Leader
9:20 am - 9:45 am
"Roles of TG2-IL6-Autophagy Regulatory Network in Cancer Survival and Chemoresistance"
9:45 am - 9:55 am
Discussion
9:55 am - 10:20 am
"The Role of TG2 in Tumor Formation in the Peritoneal Environment"
10:20 am - 10:30 am
Discussion
10:30 am - 11:00 am
Coffee Break
11:00 am - 11:25 am
"Transglutaminase Type 2 Regulation of Proteostasis and Its Implications in Metabolic Reprogramming Under Cellular Stressful Conditions"
11:25 am - 11:35 am
Discussion
11:35 am - 12:00 pm
"Loss of TG2 Sensitizes for the Development of Inflammation, Insulin Resistance and Hepatosteatosis in Mice Kept on High Fat Diet"
12:00 pm - 12:10 pm
Discussion
12:10 pm - 12:25 pm
"Analysis of Differential Expression of TG2 Variants During Treatment with Retinoic Acid Highlights a New 3'-Terminal Transcript and Putatively Involved Proteins"
12:25 pm - 12:30 pm
Discussion
12:30 pm - 1:30 pm
Lunch
1:30 pm - 4:30 pm
Free Time
4:30 pm - 6:00 pm
Poster Session
6:00 pm - 8:00 pm
Transglutaminases in Gluten-Related Disorders
6:00 pm - 6:15 pm
Introduction by Discussion Leader
6:15 pm - 6:35 pm
"TG6 Antibodies in Gluten Sensitivity-Related Neurological Dysfunction"
6:35 pm - 6:45 pm
Discussion
6:45 pm - 7:05 pm
"Celiac Anti-TG2 Autoimmunity Explored in an Immunoglobulin Knock-in Mouse"
7:05 pm - 7:15 pm
Discussion
7:15 pm - 7:30 pm
"Antibodies Against Neo-Epitope of Microbial and Human Transglutaminases in Celiac Disease"
7:30 pm - 7:35 pm
Discussion
7:35 pm - 7:45 pm
"The Future of Transglutaminase Research"
7:45 pm - 7:55 pm
Discussion
7:55 pm - 8:00 pm
Closing Remarks
8:00 pm - 9:00 pm
Dinner
Friday
7:30 am - 8:30 am
Breakfast
9:00 am
Departure